Ausgabe 3/2023
Inhalt (10 Artikel)
Endothelial-to-Mesenchymal Transition: Potential Target of Doxorubicin-Induced Cardiotoxicity
Jie Feng, Yanqing Wu
Updated Renal Dosage Recommendations for Rivaroxaban in Patients Experiencing or at Risk of Thromboembolic Disease
Albert A. Volkl, Kenneth Todd Moore, Lloyd Haskell, Elliot S. Barnathan
Prophylactic Efficacy and Safety of Antithrombotic Regimens in Patients with Stable Atherosclerotic Cardiovascular Disease (S-ASCVD): A Bayesian Network Meta-Regression Analysis
Nan Zheng, Jinyan Zhong, Xi Chen, Jia Su, Chengjiang Liu, Longfu Jiang
Hypertrophic Cardiomyopathy and Atrial Fibrillation: A Systematic Review and Meta-analysis of Anticoagulation Strategy
Federico Oliveri, Antonella Pepe, Andrea Bongiorno, Alessandro Fasolino, Francesca Romana Gentile, Sandra Schirinzi, Davide Colombo, Federico Breviario, Alessandra Greco, Annalisa Turco, Mauro Acquaro, Lorenzo Tua, Laura Scelsi, Stefano Ghio
Results From a Randomized, Open-Label, Crossover Study Evaluating the Effect of the Aldosterone Synthase Inhibitor Baxdrostat on the Pharmacokinetics of Metformin in Healthy Human Subjects
Mason W. Freeman, Mary Bond, Brian Murphy, James Hui, Jonathan Isaacsohn
A Real-World Exploration into Clinical Outcomes of Direct Oral Anticoagulant Dosing Regimens in Morbidly Obese Patients Using Data-Driven Approaches
Ezekwesiri Michael Nwanosike, Wendy Sunter, Muhammad Ayub Ansari, Hamid A. Merchant, Barbara Conway, Syed Shahzad Hasan
Characteristics and Trends in Clinical Trials of Cardiovascular Drugs in China from 2009 to 2021
Jun Hao, Chen Li, Junrong Li, Chuangshi Wang, Yang Li, Chen He, Weida Liu, Sidong Li, Ling Zuo, Wen Hui
Disparities in PCSK9 Initiation Among US Veterans with Peripheral Arterial Disease or Cerebrovascular Disease
Salil V. Deo, David McAllister, Sharon LaForest, Salah Altarabsheh, Yakov E. Elgudin, Shannon Dunlay, Simerpreet Singh, Sahil Parikh, Naveed Sattar, Jill P. Pell
Effect of Dapagliflozin Versus Empagliflozin on Cardiovascular Death in Patients with Heart Failure Across the Spectrum of Ejection Fraction: Cost per Outcome Analysis
Hilmi Alnsasra, Gal Tsaban, Adam Solomon, Fouad Khalil, Enis Aboalhasan, Jean Marc Weinstein, Joseph Azuri, Ariel Hammerman, Ronen Arbel
Clinical and Hemodynamic Responses to Imatinib in Pulmonary Veno-Occlusive Disease/Pulmonary Capillary Hemangiomatosis: A Retrospective Pilot Study of Five Cases and Review of the Literature
Junichi Nakamura, Ichizo Tsujino, Hideki Shima, Toshitaka Nakaya, Ayako Sugimoto, Takahiro Sato, Taku Watanabe, Hiroshi Ohira, Masaru Suzuki, Satonori Tsuneta, Ryo Hisada, Masaru Kato, Satoshi Konno